| Biomanufacturing (22) |  |
| Bioscience (62) | |
| Biotechnology (220) | |
| Biotechnology companies (70) | |
| Biotechnology industry (7) | |
| Biotechnology product (5) | |
| Red biotechnology (40) | |
| White biotechnology (6) | |
| Biomanufacturing (22) | |
| Bioscience (62) | |
| Biotechnology (220) | |
| Biotechnology companies (70) | |
| Biotechnology industry (7) | |
| Biotechnology product (5) | |
| Red biotechnology (40) | |
| White biotechnology (6) | |
advance manufacturing and biotechnology. e started with ICT because it the easiest thing to start.
especially by using emerging biotechnologies, and might encourage diversity in the kinds of architectures we produce.
biotechnology and information technologies to develop an artificial hand that patients were able to experience, to some degree,
#An innovative production platform for micro-products Micro-products have become increasingly important in the medical, biotechnology, consumer and automotive sectors.
We believe that the PEF will become the new world standard for polyester bottles. with the possibilities it opens up for future work in vaccine discovery was recognised with the naming of Professor Lomonossoff as Innovator of the Year 2012 by the Biotechnology and Biological sciences Research Council
was recognised with the naming of Professor Lomonossoff as Innovator of the Year 2012 by the Biotechnology and Biological sciences Research Council (BBSRC), U s
Bringing together biologists, chemists, microbiologists, biochemists, molecular geneticists and biotechnologists from universities, biotech firms and food and pharmaceutical multinationals from around Europe, Polymode has identified now its first eadingand ritingenzymes.
#PHARMA-PLANTA#Harnessing plant biotechnology to revolutionise pharmaceutical production The hope is that the drug will prove effective in preventing HIV infection.
the success of PHARMA-PLANTA"is a springboard for European plant biotechnology and will enable many important medical products to be realised".
Giaccia and Cochran are scientific advisors to Ruga Corp. a biotech startup in Palo alto that has licensed this technology from Stanford.
and the Institute for Collaborative Biotechnologies supported the work. Source: Caltechyou are free to share this article under the Creative Commons Attribution-Noderivs 3. 0 Unported license t
and the Army Research Office through the Institute for Collaborative Biotechnologies at Caltech supported the research.
Their results are published in the journal Nature Biotechnology. One billion acres#When Bt crops were introduced first the main question was how quickly would pests adapt
With some longer term, moonshot thinking around healthcare and biotechnology, I believe we can improve millions of lives.
That s exactly what#Sanaria, a biotechnology founded in 2003 by long-time malaria researcher Stephen Hoffman and based in a suburb of Washington,
Includes the broad redefinition and expansion of biotechnology, with the ultimate goals of being able to design,
like a living cockroach, says Ángel Goñi Moreno of the National Center for Biotechnology in Madrid,
An expert on sustainable agriculture and the potential environmental risks of biotechnology Mellon holds a doctorate in molecular biology and a law degree.
the Wellcome Trust has joined forces with the Indian government's Department of Biotechnology to fund postdoctoral researchers in the country through a new,
It was in August 2009, that Sherley and Theresa Deisher, the chief executive of AVM Biotechnology in Seattle,
Lu says that the approach could also be useful in biotechnology. Using simple forms of these addressable switches,
as well as the launch of several SMALL CAR-focused biotechnology firms. And Sadelein says that he is an investigator on a trial with the Dana-Farber Cancer Institute in Boston
"It s a huge unmet need, says David Ferreiro, a biotechnology analyst with investment bank Oppenheimer & Company in New york,
and Hudsonalpha Institute for Biotechnology, was published today in the online edition of Science. he identification of TBK1 is exciting for understanding ALS pathogenesis,
including bladder cancer. rology hasn gotten really the benefit of improvement in the biotech revolution. This type of technology can revolutionize how we do drug therapy in urology,
Indeed, collecting clinical data is a major challenge in spinning biotechnology out of the lab, notes Cima,
Biologics is the fastest growing field in biotech because it gives you the ability to do highly predictive designs with unique targeting capabilities says senior author Mehmet Fatih Yanik an associate professor of electrical engineering and computer science and biological engineering.
and electrical engineering and computer science the researchers described their findings in the Sept. 21 issue of Nature Biotechnology.
In the new Nature Biotechnology study graduate students Robert Citorik and Mark Mimee worked with Lu to target specific genes that allow bacteria to survive antibiotic treatment.
which have numerous applications in a variety of fields including biotechnology. He adds This work cleverly combines low-hysteresis droplet movement with low-magnetic-field-driven droplet propulsion to achieve impressive capabilities.
The company which aims to leverage biotechnology as a way to solve environmental issues is also modifying their system to generate value from wastewater in agricultural and military fields,
We are leveraging biotechnology to provide the highest return on investment for managing water. To that end, Cambrian is working on other projects that leverage exoelectrogenic microbes to treat wastewater.
Meeting at MIT in 2006 over a shared fondness for biotech, Silver, then a research scientist in MIT Space Systems Lab,
is to leverage biotechnology to advance a sustainable ndustrial ecology, where the waste of industry is recycled to create energy
The findings described in the March 30 issue of Nature Biotechnology offer the first evidence that this gene-editing technique known as CRISPR can reverse disease symptoms in living animals.
and one of the lead authors of the Nature Biotechnology paper. This work shows that CRISPR can be used successfully in adults
and the Institute for Collaborative Biotechnologies through the U s army Research Office u
#Resistance is futile Cisplatin is given a chemotherapy drug to more than half of all cancer patients. The drug kills cells very effectively by damaging nuclear DNA but if tumors become resistant to cisplatin they often grow back.
In the previous version of the system reported last December in Nature Biotechnology the researchers used mass spectrometry to distinguish the fragments by their mass.
the biomaterial has positioned Semprus as a fast-growing biotech firm in Kendall Square. In its six years, the startup seed-funded, in part,
The new technology is described in a paper appearing in the journal Nature Biotechnology, written by MIT Polina Anikeeva and 10 others.
Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable,
Invented by Microchips Biotech cofounders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs,
and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
Microchips Biotech says these microchips could also improve medication-prescription adherence a surprisingly costly issue in the United states. A 2012 report published in the Annals of Internal medicine estimated that Americans who don stick to prescriptions rack up $100 billion to $289 billion
Microchips Biotech will continue work on its flagship product, a birth-control microchip, backed by the Bill and Melinda Gates Foundation,
Cima, who now serves on the Microchips Biotech board of directors with Langer, sees this hormone-releasing microchip as one of the first implantable rtificial organsecause it acts as a gland. lot of the therapies are trying to chemically trick the endocrine systems Cima says. e are doing that with this artificial organ we created. ild ideasinspiration for the microchips came in the late 1990s,
For years, the technology underwent rigorous research and development at Microchips Biotech. But in 2011, Langer and Cima,
EMS innovationsmicrochips Biotech made several innovations in the microelectromechanical systems (MEMS) manufacturing process to ensure the microchips could be commercialized.
To do so, Microchips Biotech modified a cold-welding ongue and grooveprocess. This meant depositing a soft,
The research team received funding for their study from the Israel Ministry of Science and Technology the European Research Council and the Biotechnology and Biological sciences Research Council.
Dr. Tal Dvir and his graduate student Michal Shevach of TAU's Department of Biotechnology, Department of Materials science and engineering,
"said Ali Yetisen, a Phd candidate in the Department of Chemical engineering & Biotechnology, who led the research.
That s just what a group of MIT researchers have done in a new study published in the journal Nature Biotechnology.
Genetic engineering and Biotechnology News explains: The team began studying reflectin to discern how it enables the squid to change color
Church also is cofounder of the biotech firm Editas Medicine. He said he expects the company will enter clinical trials next year on a gene-editing process for humans e
The study, funded by the Engineering and Physical sciences Research Council and the Biotechnology and Biological sciences Research Council, is published in Proceedings of the National Academy of Sciences.
a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense
Most tech innovation in agriculture was concentrated narrowly in biotechnology and seed genetics, and both investment and innovation was limited to players with close ties to the ag sector.
and the sector is described often as being more horizontal than vertical (we tracked 16 subcategoriess diverse as biotech,
The North carolina Biotechnology Center awarded a $50, 000 Technology Enhancement Grant to the School to help develop the technology into a viable treatment that can be licensed and commercialized."
#Self-Assembled DNA NANOSTRUCTURES Could Be used as Smart Drug-Delivery Vehicles Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal.
and the group has published just recently two research articles regarding DNA-based applications in biotechnology and molecular medicine.
a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense
Now MIT spinout AIM Biotech has developed a microfluidics device based on years of research that lets researchers co-culture multiple cell types in a 3d hydrogel environment that mimics natural tissue.
said AIM Biotech cofounder Roger Kamm, the Cecil H. Green Distinguished Professor in MIT departments of mechanical engineering and biological engineering. f you want realistic models of these processes,
AIM Biotech will begin deploying the commercial devices to 47 research groups in 13 countries for user feedback.
AIM Biotech devices, on the other hand, he said, can be put directly under the microscope like a traditional plate,
IM Biotech launched in Singapore in 2012, under current CEO Kuan Chee Mun, who Kamm met through SMART.
AIM Biotech microfluidics device produces a similar microenvironment: When endothelial cells are seeded into the side channels or the central gel region,
AIM Biotech may offer to more accurately screen cancer drugs for pharmaceutical companies. In fact, he said, AIM Biotech recently discovered that its devices revealed discrepancies in some clinically tested therapeutics.
In a study published in Integrative biology, MIT researchers used Kamm's microfluidics technology to screen several drugs that aim to prevent tumors from breaking up
biotechnology and medical treatments. The study appears September 21 in Nature Materials. he very simple design rules that we have discovered provide a powerful engineering tool for many biomedical
a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense
physiology and biotechnology and associate professor of engineering at Brown. e knew it was a relatively high-throughput system,
the Wellcome Trust and the Biotechnology and Biological sciences Research Council will be published in the science journal Oncogene on 5 october 2015.
The historical irony is that Europe once led in biotech: In 1983, Marc Van Montagu and Jeff Schell at the University of Ghent in Belgium introduced the world to modern plant genetic engineering.
because biotech traits make them cheaper. Yet these same traits such as herbicide tolerance and insect resistance are barred now widely from domestic use.
I was interrupted by an organic farmer who said he was determined never to grow biotech crops. His grounds?
Yet from drought tolerant maize to virus-resistant cassava, many biotech traits are being developed that could quickly improve the livelihoods of poorer African farmers.
"In close collaboration with his TUM colleagues Johannes Buchner, professor of biotechnology and Sevil Weinkauf, professor of electron microscopy, Reif determined that the small heat shock protein uses a specific nonpolar beta-sheet structure pile in its center
The Córdoba-based company Canvax Biotech has participated also in the development of the patent. A nontoxic drug One of the major advantages of the drug is that it is nontoxic.
In the last two months, the research project has received funding of over#124,930 from the public sector from the Ministry of Economy and Finance and the firm Canvax Biotech SL and#20
"What we found may have a big impact on future plant biotechnology research, "Dr Bally said."
and biotechnology can join forces.""Professor Sels, is of KU Leuven Faculty of Bioscience Engineering (Centre for Surface Chemistry and Catalysis),
the researchers used biotechnology to create the proteins in bacteria. The polymer can then either be molded using heat
was funded by Cancer Research UK, the Wellcome Trust and the Biotechnology and Biological sciences Research Council h
The research jointly lead by Professor Christoph Hagemeyer, Head of the Vascular Biotechnology Laboratory at Baker IDI Heart and Diabetes Institute and Professor Frank Caruso,
Owing to the above-mentioned merits, SPR biosensing is an outstanding platform to boost technological progress in the areas of medicine and biotechnology.
As they report Sept. 28 in Nature Biotechnology, this tool should provide fast and reliable characterization of the different mechanisms cellular proteins use to bind to DNA strands--information that could shed new light on the atomic-scale interactions within our cells
In this latest study, published in the journal Biotechnology for Biofuels("A microbial platform for renewable propane synthesis based on a fermentative butanol pathway"),scientists at the Universitys Manchester Institute of Biotechnology (MIB
more sustainable forms of energy as well as using biotechnology techniques to produce synthetic chemicals are currently being developed at The University of Manchester.
"The challenge of the biotechnologists Tamara Wriessnegger and Harald Pichler in Graz was to produce Nootkatone in large quantities.
The common biotech variant via Valencene and a chemical synthesis step is less ecofriendly, more difficult and expensive.
developed by researchers at University college London with funding from the Biotechnology & Biological sciences Research Council (BBSRC),
The research jointly lead by Professor Christoph Hagemeyer, Head of the Vascular Biotechnology Laboratory at Baker IDI Heart and Diabetes Institute and Professor Frank Caruso,
the researchers used biotechnology to create the proteins in bacteria. The polymer can then either be molded using heat
biotechnology and medical treatments. The study appears September 21 in Nature Materials("Sequence Heuristics To Encode Phase Behaviour In Intrinsically Disordered Protein Polymers"."
a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense
Owing to the above-mentioned merits, SPR biosensing is an outstanding platform to boost technological progress in the areas of medicine and biotechnology.
As they report Sept. 28 in Nature Biotechnology("Subangstrom single-molecule measurements of motor proteins using a nanopore),
"What we found may have a big impact on future plant biotechnology research, "Dr Bally said."
a biotechnologist who has helped developed stem cell-based treatments for ischemic diseases. The Hoope idea originated from a NASA camp where Damel team bested 80 other scientists in developing an impactful product.
Now, researchers from the Technical University of Dortmund in Germany have outlined in the journal Biotechnology Letters how they looked into
The study appears online April 6 in Nature Biotechnology.""The epigenome is associated everything with the genome other than the actual genetic sequence,
The research was supported by a University of California Discovery Biotechnology Award, the National institutes of health, Nanocav and the National Science Foundation n
"The discovery will also be useful in the biotechnology field for the development of a variety of marketable products
therefore necessary for the production of gibberellins--a mechanism that is highly relevant to the growth and development of plants,"says Poppenberger, Professor for the Biotechnology of Horticultural Crops.
This biotechnology method could also have similar applications to other low-concentration ions in solution.
A major goal in biotechnology is to modify enzyme activity in order to carry out bespoke reactions. Current methods use genetic engineering to physically mutate enzymes.
Next steps Biotechnologists know how to build the complex protein structures they find in nature, but the Stanford team took this further.
biotechnology and medical treatments.""The very simple design rules that we have discovered provide a powerful engineering tool for many biomedical
which Jin-Soo Kim points out,"paves the way for the widespread use of RNA-guided genome editing in plant biotechnology and agriculture."
This technological breakthrough hails opportunities for the development of smaller and cheaper sensors for various fields such as consumer electronics, information and communication technology, biotechnology and automotive.
where the specific marker shows in a few seconds,"explains project coordinator Dr. Marco Antonio Rite Palomares, director of the Biotechnology Center of the Tec de Monterrey FEMSA.
The director of FEMSA Biotechnology Center mentions that he considered using the camera phone to detect the marker in saliva,
The results were published today in two Nature Biotechnology reports. Sequencing the genome of Upland cotton (Gossypium hirsutum) will help breeders develop varieties of cotton that are equipped better to combat the pests,
are the lead authors in a study published in the April 20 edition of the journal Nature Biotechnology.
With the financial aid of a biotechnology executive whose daughter may need a lung transplant, U s. researchers have been shattering records in xenotransplantation,
The technology might also pave the way to new biotech drugs. Nearly all such drugs
#South korea to invest $300m in biotech The South korean Ministry of Science, ICT and Future Planning, the Ministry of Trade, Industry and Energy,
and other local agencies have announced plans to invest $300 million in fostering biotechnology over the course of 2015
As of 2012, it controlled just 1. 3 percent share in global biotechnology, the ministries said.
Biotechnology is quickly gaining popularity in South korea, the government said, with startups working on the area accounting for 13.7 percent of listed companies on the KOSDAW based on market value.
Venture capitalists invested a total of $225 million in biotech last year more than IT manufacturing's $150. 8 million and IT services'$131 million.
The government expects the global biotechnology market to see rapid growth, and expects it to dwarf the semiconductor, chemical,
RNA interference was identified more than a decade ago launching a new research field that has spawned a Nobel prize and new biotech firms.
and metal--and also suppressed biofilm formation in a study reported in Nature Biotechnology. But that's not All the team implanted medical-grade tubing
since the earliest days of endoscopy,"says Timo Cuntz, a member of the Project Group for Automation in Medicine and Biotechnology PAMB in Mannheim, a part of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA.
'A new method developed at the Centre for Plant Biotechnology and Genomics (CBGP UPM-INIA) has shown that by the contact of a plant with a strain of the Colletotrichum tofieldiae microorganism previously isolated this plant can increase the number size
pageac=patente. jsp&idpatente=812) and there is an exclusive commercial patent license agreement with Plant Response Biotech S l. a spin-off company from the Universidad Politécnica de Madrid created in 2008 that focuses its work on the development
and biotechnology to precisely manipulate small volumes of fluids for use in applications such as enzymatic or DNA analysis pathogen detection clinical diagnostic testing and synthetic chemistry.
For the past 20 years microfluidics has been considered a boon for fields like biotechnology and engineering but has yet to be standardized
After developing Cellsqueeze at MIT, Sharei co-founded SQZ Biotech in 2013 to further develop and commercialize the platform.
Meanwhile, SQZ Biotech aims to reduce the footprint of its device, which could potentially lower the time
biotechs race to develop acute radiation drugs Since the nuclear crisis at the Fukushima Daiichi power station,
#Where the bio-rubber meets the road My posts about biotechnology as it relates to agriculture tend to draw impassioned naysayers,
but surely here's a biotech application with which they can relate: a renewable fermentation process that seeks to act as a partial replacement for the an oil-based processes that goes into making synthetic rubber.
The work was published in Nature Biotechnology this week. And just last week Technology Review reported that Roche backed off its hostile takeover bid for Illumina,
both have an extensive background in biotechnology. At age 18, Erik Gatenholm started his first medical device company, manufacturing meniscus implants and other implants, such surgical meshes for ventral hernia repairs and wound dressings.
but also pave the way for more complex optical fiber structures that are able to host a variety of applications for industries ranging from telecommunications and aerospace to biotechnologies and more."
Emiliana De Santis, who is developing the standard in NPL's Biotechnology Group, said:""Our ability to exploit self-assembly processes allows us to enable
biotechnology and nanobiotechnology for applications including targeted drug delivery. Chirality of an object is its property that allows it to be non-superimposable with its mirror image.
which also has an area of`Biotechnology and Drug Research of Biomedical engineering, Diagnosis and Treatment Equipment.
Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable,
Invented by Microchips Biotech cofounders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs,
and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
Apart from providing convenience, Microchips Biotech says these microchips could also improve medication-prescription adherence a surprisingly costly issue in the United states. A 2012 report published in the Annals of Internal medicine estimated that Americans who don stick to prescriptions rack up $100 billion
Microchips Biotech will continue work on its flagship product, a birth-control microchip, backed by the Bill and Melinda Gates Foundation,
Cima, who now serves on the Microchips Biotech board of directors with Langer, sees this hormone-releasing microchip as one of the first implantable rtificial organsbecause it acts as a gland. lot of the therapies are trying to chemically trick the endocrine systems Cima says. e are doing that with this artificial organ we created.
For years, the technology underwent rigorous research and development at Microchips Biotech. But in 2011, Langer and Cima,
MEMS innovations Microchips Biotech made several innovations in the microelectromechanical systems (MEMS) manufacturing process to ensure the microchips could be commercialized.
To do so, Microchips Biotech modified a cold-welding ongue and grooveprocess. This meant depositing a soft,
biotechnology and instrumentation expertise to develop a portable, autonomous device that analyzes trace elements. The highly miniaturized microbial analysis machine,
Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable,
Invented by Microchips Biotech cofounders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs,
and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,
Apart from providing convenience, Microchips Biotech said these microchips could also improve medication-prescription adherence a surprisingly costly issue in the United states. A 2012 report published in the Annals of Internal medicine estimated that Americans who don stick to prescriptions rack up $100 billion
Microchips Biotech will continue work on its flagship product, a birth-control microchip, backed by the Bill and Melinda Gates Foundation,
Cima, who now serves on the Microchips Biotech board of directors with Langer, sees this hormone-releasing microchip as one of the first implantable rtificial organsbecause it acts as a gland. lot of the therapies are trying to chemically trick the endocrine systems Cima said. e are doing that with this artificial organ we created.
For years, the technology underwent rigorous research and development at Microchips Biotech. But in 2011, Langer and Cima,
MEMS innovations Microchips Biotech made several innovations in the microelectromechanical systems (MEMS) manufacturing process to ensure the microchips could be commercialized.
To do so, Microchips Biotech modified a cold-welding ongue and grooveprocess. This meant depositing a soft,
#New Single-use Harvesting Technology for High Cell Density Cultures Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced Sartoclear Dynamics,
Sartorius Stedim Biotech has developed now this robust technology for biotech applications. Specially designed for cgmp processing
which is attractive for newcomers from emerging biotech markets. The ready-to-use clarification system enables harvesting of high cell density cultures up to 2, 000 liters 0
one of the authors of the study and Professor of Biotechnology and Therapeutics at the Graduate school of Pharmaceutical Sciences at Osaka University. ecause the new patch is so easy to use,
the research team included Professor Vladimir Tsukruk from the Georgia Tech School of Materials science and engineering and Rajesh Naik, Biotechnology Lead and Tech Advisor of the Nanostructured and Biological Materials Branch
#State Deficits to Shrink & Taxes Drop-Good News for Biotech Forecasters at the National Conference of State Legislatures2011 Legislative Summit expect a dramatic reduction of state deficits in the coming years,
Biotech start-ups generally struggle to raise capital to finance their research, and BIO advocates two important policies that enable them to continue critical R&d of advancements and breakthroughs.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011